Table 3.
Treatment | Striatum | Cortex | Hypothalamus |
---|---|---|---|
After 3 h | |||
Sham | ND | ND | ND |
Vehicle | 32 ± 4 | 28 ± 1 | 20 ± 3 |
S-AMPA | 28 ± 6 | 86 ± 23 | 26 ± 7 |
hrIL-1β | 29 ± 3 | 56 ± 20 | 41 ± 4 |
S-AMPA + hrIL-1β | 47 ± 9 | 128 ± 27* | 56 ± 9**,† |
After 8 h | |||
Sham | ND | ND | ND |
Vehicle | 157 ± 46‡ | 65 ± 20 | 18 ± 3 |
S-AMPA | 48 ± 7 | 72 ± 10 | 35 ± 7 |
hrIL-1β | 304 ± 70††,‡ | 147 ± 41 | 128 ± 30**,†,‡ |
S-AMPA + hrIL-1β | 241 ± 34†,‡‡ | 870 ± 186***,†††,‡,§§§ | 186 ± 27***,†††,‡ |
Expression of immunoreactive rat IL-1β (pg IL-1β/mg protein) in different regions of the rat brain 3 h and 8 h after intrastriatal injection (n = 4–6) of vehicle, S-AMPA (7.5 nmol), hrIL-1β (10 ng) or S-AMPA (7.5 nmol) + hrIL-1β (10 ng). ∗, P < 0.05; ∗∗, P < 0.01; ∗∗∗, P < 0.001 vs. vehicle. †, P < 0.05, ††, P < 0.01, †††, P < 0.001 vs. S-AMPA. ‡, P < 0.05; ‡‡, P < 0.01 vs. 3 h; §§§, P < 0.001 vs. hrIL-1β. ND, not detectable.